⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
TPST News
Tempest Therapeutics, Inc. Common Stock
Tempest Announces Partnership for TPST-2003 in Preparation for Planned U.S. Registrational Study in 2026
globenewswire.com
TPST
Form 8-K
sec.gov
TPST
Tempest Announces Interim Results from Ongoing REDEEM-1 Trial of TPST-2003, Preparing for Potential U.S. Registrational Study in 2026
globenewswire.com
TPST
Tempest Lays Out Strategic Plan to Advance Recently Acquired Dual-Targeting CAR-T Assets
globenewswire.com
TPST
Tempest Announces Closing of Strategic Acquisition of Dual-Targeting CAR-T Assets
globenewswire.com
TPST
Tempest Announces Record Date for Anticipated Dividend Distribution of Warrants to Stockholders
globenewswire.com
TPST
Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
globenewswire.com
TPST
Tempest Announces Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
globenewswire.com
TPST
Tempest Announces Strategic Acquisition of New Dual-CAR T Programs from Factor with Simultaneous Runway Extension Projected to Mid 2027
globenewswire.com
TPST
BTX
Tempest Reports Third Quarter 2025 Financial Results and Provides Business Update
globenewswire.com
TPST